Novel Equations for Estimating Lean Body Mass in Patients With Chronic Kidney Disease
1 other identifier
observational
300
1 country
1
Brief Summary
Simplified methods to estimate lean body mass (LBM), an important nutritional measure representing muscle mass and somatic protein, are lacking in non-dialyzed patients with chronic kidney disease (CKD). Objective: We developed and tested a reliable equations for estimation of LBM in daily clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 28, 2019
CompletedFirst Posted
Study publicly available on registry
August 30, 2019
CompletedSeptember 10, 2019
September 1, 2019
2.8 years
August 28, 2019
September 7, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LBM_DEXA
lean body mass measured by dual-energy x-ray absorptiometry (DEXA)
between March 1st, 2014 and December 1st, 2015
Study Arms (2)
development groups
The development groups included 150 patients derived from outpatients in Peking University First Hospital, between March 1st, 2014 and November 26th 2014.
validation groups
The validation groups included 150 patients derived from outpatients in Peking University First Hospital, between November 27th 2014 and December 1st, 2015.
Eligibility Criteria
The development and validation groups both included 150 non-dialyzed patients with CKD stage 3-5.
You may qualify if:
- non-dialyzed patients with CKD stage 3-5
- clinical stable
- a willingness to be examined with all measurements being taken simultaneously.
You may not qualify if:
- systemic infections, acute cardiovascular events, operations, trauma, active hepatitis or tumor
- severe edema within one month prior to the study
- chronic infections, connective tissue disease, hyper- or hypothyroidism, amputations or pregnancy,
- taking immunosuppressive agents and anti-inflammatory medication chronically
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Renal Division and Institute of Nephrology, Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor of Institute of Nephrology, Division of Renal
Study Record Dates
First Submitted
August 28, 2019
First Posted
August 30, 2019
Study Start
March 1, 2013
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
September 10, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share